NYSE:CMD

Cantel Medical Stock Forecast, Price & News

$80.37
0.00 (0.00 %)
(As of 06/2/2021)
Add
Compare
Today's Range
$80.37
$80.37
50-Day Range
$80.37
$89.66
52-Week Range
$39.40
$89.76
VolumeN/A
Average Volume626,604 shs
Market Capitalization$3.58 billion
P/E Ratio69.28
Dividend YieldN/A
Beta1.55
30 days | 90 days | 365 days | Advanced Chart
Receive CMD News and Ratings via Email

Sign-up to receive the latest news and ratings for Cantel Medical and its competitors with MarketBeat's FREE daily newsletter.


Cantel Medical logo

About Cantel Medical

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.14 out of 5 stars

Medical Sector

1024th out of 2,100 stocks

Surgical & Medical Instruments Industry

98th out of 174 stocks

Analyst Opinion: 1.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Cantel Medical (NYSE:CMD) Frequently Asked Questions

Is Cantel Medical a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cantel Medical in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Cantel Medical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CMD, but not buy additional shares or sell existing shares.
View analyst ratings for Cantel Medical
or view top-rated stocks.

What stocks does MarketBeat like better than Cantel Medical?

Wall Street analysts have given Cantel Medical a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cantel Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Cantel Medical's earnings last quarter?

Cantel Medical Corp. (NYSE:CMD) issued its quarterly earnings results on Monday, March, 8th. The company reported $0.79 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.50 by $0.29. The business earned $294 million during the quarter, compared to the consensus estimate of $276.63 million. Cantel Medical had a trailing twelve-month return on equity of 12.13% and a net margin of 4.72%. The company's quarterly revenue was up 1.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.61 earnings per share.
View Cantel Medical's earnings history
.

How has Cantel Medical's stock been impacted by COVID-19 (Coronavirus)?

Cantel Medical's stock was trading at $49.70 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CMD shares have increased by 61.7% and is now trading at $80.37.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for CMD?

4 equities research analysts have issued 12 month price targets for Cantel Medical's stock. Their forecasts range from $51.00 to $100.00. On average, they anticipate Cantel Medical's share price to reach $73.67 in the next year. This suggests that the stock has a possible downside of 8.3%.
View analysts' price targets for Cantel Medical
or view top-rated stocks among Wall Street analysts.

Who are Cantel Medical's key executives?

Cantel Medical's management team includes the following people:
  • Mr. Charles Michael Diker, Chairman & Member of Office of the Chairman (Age 86, Pay $373.47k)
  • Mr. George L. Fotiades, CEO, Vice Chairman & Member of Office of the Chairman (Age 67, Pay $667.67k)
  • Mr. Peter G. Clifford, Pres & COO (Age 51, Pay $560.62k)
  • Mr. Shaun M. Blakeman, Sr. VP, CFO & Member of Office of the Chairman (Age 43, Pay $404.63k)
  • Mr. Jeffrey Z. Mann, Sr. VP, Gen. Counsel, Corp. Sec. & Member of Office of the Chairman (Age 48, Pay $369.12k)
  • Mr. Seth M. Yellin, Exec. VP of Strategy & Corp. Devel. (Age 47, Pay $424.38k)
  • Mr. Michael Drexel, CTO & Sr. VP
  • Ryan Lada, VP of Investor Relations
  • Ms. Milicent Brooks, Head of Corp. Communications
  • Ms. Jean M. Casner, Sr. VP & Chief HR Officer (Age 63)

Who are some of Cantel Medical's key competitors?

What other stocks do shareholders of Cantel Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cantel Medical investors own include Gilead Sciences (GILD), JPMorgan Chase & Co. (JPM), Medtronic (MDT), NVIDIA (NVDA), Cisco Systems (CSCO), Netflix (NFLX), Broadcom (AVGO), Alibaba Group (BABA), Bank of America (BAC) and Citigroup (C).

What is Cantel Medical's stock symbol?

Cantel Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "CMD."

Who are Cantel Medical's major shareholders?

Cantel Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.92%), Champlain Investment Partners LLC (9.00%), JPMorgan Chase & Co. (4.21%), Citadel Advisors LLC (2.32%), Citadel Advisors LLC (2.32%) and Credit Suisse AG (2.20%). Company insiders that own Cantel Medical stock include Ann E Berman, Anthony B Evnin, Brian Capone, Charles M Diker, George L Fotiades, Jeffrey Z Mann and Mark N Diker.
View institutional ownership trends for Cantel Medical
.

Which institutional investors are selling Cantel Medical stock?

CMD stock was sold by a variety of institutional investors in the last quarter, including Fred Alger Management LLC, Brown Capital Management LLC, Janus Henderson Group PLC, Royal Bank of Canada, Glenmede Trust Co. NA, Emerald Advisers LLC, Ameriprise Financial Inc., and Emerald Mutual Fund Advisers Trust. Company insiders that have sold Cantel Medical company stock in the last year include Ann E Berman, and Brian Capone.
View insider buying and selling activity for Cantel Medical
or view top insider-selling stocks.

Which institutional investors are buying Cantel Medical stock?

CMD stock was acquired by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, Citadel Advisors LLC, Grantham Mayo Van Otterloo & Co. LLC, Alpine Associates Management Inc., Water Island Capital LLC, Goldman Sachs Group Inc., CNH Partners LLC, and Man Group plc. Company insiders that have bought Cantel Medical stock in the last two years include Anthony B Evnin, George L Fotiades, Jeffrey Z Mann, and Mark N Diker.
View insider buying and selling activity for Cantel Medical
or or view top insider-buying stocks.

How do I buy shares of Cantel Medical?

Shares of CMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cantel Medical's stock price today?

One share of CMD stock can currently be purchased for approximately $80.37.

How much money does Cantel Medical make?

Cantel Medical has a market capitalization of $3.58 billion and generates $1.02 billion in revenue each year. The company earns $13.71 million in net income (profit) each year or $1.65 on an earnings per share basis.

How many employees does Cantel Medical have?

Cantel Medical employs 3,669 workers across the globe.

What is Cantel Medical's official website?

The official website for Cantel Medical is www.cantelmedical.com.

Where are Cantel Medical's headquarters?

Cantel Medical is headquartered at 150 CLOVE ROAD, LITTLE FALLS NJ, 07424.

How can I contact Cantel Medical?

Cantel Medical's mailing address is 150 CLOVE ROAD, LITTLE FALLS NJ, 07424. The company can be reached via phone at 973-890-7220 or via email at [email protected]


This page was last updated on 6/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.